Effect of Glycosphingolipids Purified from Leishmania (Leishmania) amazonensis Amastigotes on Human Peripheral Lymphocytes

Selma Giorgio; Marcia Regina M. Santos; Anita H. Straus; Helio K. Takahashi; Clara Lúcia Barbiéri

首页> 外文期刊>Clinical and diagnostic laboratory immunology >Effect of Glycosphingolipids Purified from Leishmania (Leishmania) amazonensis Amastigotes on Human Peripheral Lymphocytes

【24h】

Effect of Glycosphingolipids Purified from Leishmania (Leishmania) amazonensis Amastigotes on Human Peripheral Lymphocytes

机译：从亚马逊利什曼原虫（Leishmania）Amazon amagonensis Amastigotes纯化的糖鞘脂对人外周血淋巴细胞的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The effect of purified glycosphingolipids from Leishmania (Leishmania) amazonensis on human lymphoproliferation, on expression of human lymphocyte and monocyte markers (CD3, CD4, CD8, CD14, CD19, and CD45), and on lymphocyte protein kinase C activity was analyzed.

机译：纯化的利什曼原虫（利什曼原虫）亚马逊的鞘糖脂对人淋巴增殖，对人淋巴细胞和单核细胞标志物（CD3，CD4，CD8的表达）的影响，CD14，CD19和CD45），并分析了淋巴细胞蛋白激酶C的活性。 展开▼

著录项

来源
《Clinical and diagnostic laboratory immunology》 |2003年第3期|共4页

作者
Selma Giorgio; Marcia Regina M. Santos; Anita H. Straus; Helio K. Takahashi; Clara Lúcia Barbiéri;
展开▼

作者单位

展开▼

收录信息

原文格式 PDF

正文语种

中图分类诊断学;

关键词

相似文献

外文文献

中文文献

专利

1. Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity [J] . A.h. Straus, A.k. Tanaka, H.k. Takahashi, Brazilian Journal of Medical and Biological Research . 2007,第6期

机译：利什曼原虫（Leishmania）amazonensis鞭毛体糖鞘脂在巨噬细胞感染性中的作用

2. Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity [J] . Tanaka A.K., Gorin P.A.J., Takahashi H.K., Brazilian Journal of Medical and Biological Research . 2007,第6期

机译：利什曼原虫（Leishmania）amazonensis鞭毛体糖鞘脂在巨噬细胞感染性中的作用

3. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody. [J] . C L Barbiéri, S Giorgio, A J Merjan, Infection and immunity . 1993,第5期

机译：利什曼原虫（Leishmania）amazonensis amastigotes的糖鞘脂抗原通过使用单克隆抗体鉴定。

4. Efficacy of the Photodynamic Antimicrobial Therapy (PACT) with the use of Methylene Blue Associated with the X660nm laser in Leishmania (Leishmania) amazonensis: In Vitro Study [C] . Gustavo M. Pires-Santos, Aparecida M. C. Marques, Elisamara S.S. Alves, Mechanisms for low-light therapy VII . 2012

机译：亚甲蓝与X660nm激光联合应用光动力学抗菌疗法（PACT）在亚马逊利什曼原虫（Leishmania）中的功效：体外研究

5. Differential regulation of dendritic cell migration after Leishmania major and Leishmania amazonensis infection [D] . Soto Ruiz, Victor Raul 2007

机译：大利什曼原虫和亚马逊利什曼原虫感染后树突状细胞迁移的差异调节

6. Effect of Glycosphingolipids Purified from Leishmania (Leishmania) amazonensis Amastigotes on Human Peripheral Lymphocytes [O] . Selma Giorgio, Marcia Regina M. Santos, Anita H. Straus, 2003

机译：从亚马逊利什曼原虫（Leishmania）Amastigotes纯化的糖鞘脂对人外周血淋巴细胞的影响

7. Effect of glycosphingolipids purified from Leishmania (Leishmania) amazonensis amastigotes on human peripheral lymphocytes [O] . Giorgio, S, Santos, MRM, Straus, AH, 2015

机译：从亚马逊利什曼原虫（Leishmania）亚马逊变形虫纯化的鞘糖脂对人外周血淋巴细胞的影响

8. Human Monocyte Activation for Cytotoxicity against Intracellular Leishmania donovani Amastigotes: Induction of Microbicidal Activity by Interferon-Gamma [R] . Hoover, D. L., Nacy, C. A., Meltzer, M. S. 1985

机译：人单核细胞激活对细胞内杜氏利什曼原虫无毒鞭毛体的细胞毒性：干扰素-γ诱导杀微生物活性

1. 肝片吸虫鞘脂激活蛋白样蛋白2(FhSAP-2)的原核表达及分离纯化 [J] . 李润乐 ,康明 ,汤锋 . 青海医学院学报 . 2014,第001期

2. 糖鞘脂GM1调控生长密度相关的乳腺细胞体外增殖抑制 [J] . 卓定浩 ,关锋 . 生物化学与生物物理进展 . 2019,第005期

3. 糖鞘脂的生物学功能及相关药物开发研究 [J] . 关锋 . 生物产业技术 . 2018,第006期

4. 糖鞘脂分析技术及相关疾病研究进展 [J] . 杜昊骐 ,于汉杰 ,贾丽苑 . 生物化学与生物物理进展 . 2016,第001期

5. 甘露糖赤藓糖醇脂分离纯化条件的研究 [J] . 朱文昌 ,陈坚 . 日用化学工业 . 1998,第003期

6. 甘露糖赤藓糖醇脂发酵条件及分离纯化的初步研究 [C] . 朱文昌 . 第七届全国生物化工学术会议 . -1

7. 利什曼原虫脂磷聚糖(LPG)相关四糖合成砌块的高效合成研究 [A] . AIMAN SALEH A.MOHAMMED . 2020

1. 没有被非常规病毒污染的糖神经鞘脂混合物的制备与纯化方法 [P] . 中国专利： CN1027895C . 1995.03.15

2. 没有被非常规病毒污染的糖神经鞘脂混合物的制备与纯化方法 [P] . 中国专利： CN1053067A . 1991-07-17

3. a composition comprising fractions or sub-fractions of leishmania promastigotes or amastigotes called fucose mannose ligand (fml) and saponin, a composition for preparing leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or amastigotes (fml) ) and saponin, use of the composition in the preparation of blocking vaccines to prevent the transmission of human or animal visceral leishmaniasis, use of the composition in the preparation of reagents consisting of administration of fractions or sub-fractions of leishmania promastigotes or amastigotes called fucose mannose ligand ( fml) and saponin [P] . 外国专利： BRPI0503187A . 2007-01-23

机译：包含利什曼原虫前鞭毛体或变形虫称为岩藻糖甘露糖配体（fml）和皂苷的级分或亚级分的组合物，用于制备人和动物中利什曼病传播阻断疫苗的组合物，包含利什曼原虫前体或变形虫（fml）的级分或亚级分皂苷，该组合物在制备预防人或动物内脏利什曼病传播的封闭疫苗中的用途，该组合物在制备利什曼原虫前鞭毛体或变形虫的级分或亚级分称为岩藻糖甘露糖的试剂中的用途配体（fml）和皂苷

4. Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis [P] . 外国专利： US2009208536A1 . 2009-08-20

机译：包含利什曼原虫前鞭毛体或利什曼原虫利什曼原虫称为岩藻糖甘露糖配体（fml）和皂苷的级分或亚级分的组合物，用于制备人和动物中利什曼病传播阻断疫苗的组合物，其包含利什曼原虫前体或莱氏菌级分或亚级分

5. COMPOSITION COMPRISING FRACTIONS OR SUB-FRACTIONS OF LEISHMANIA PROMASTIGOTES OR LEISHMANIA AMASTIGOTES CALLED FUCOSE MANNOSE LIGAND (FML) AND SAPONIN, COMPOSITION FOR PREPARATION OF LEISHMANIASIS TRANSMISSION BLOCKING VACCINES IN HUMANS AND ANIMALS COMPRISING FRACTIONS OR SUB-FRACTIONS OF LEISHMANIA PROMASTIGOTES OR LEIS [P] . 外国专利： WO2006122382A2 . 2006-11-23

机译：包含利什曼原虫繁殖体或利什曼原虫吻合的果葡糖配体配体（FML）和皂苷的成分或亚成分的组合物，用于制备人类中利什曼原虫传播阻断性疫苗的动物和由动物或动物组成的构成部分

相关主题

Effect of Glycosphingolipids Purified from Leishmania (Leishmania) amazonensis Amastigotes on Human Peripheral Lymphocytes

摘要

著录项

相似文献

相关主题

期刊订阅